The Adult Smoker Considering Switching
Key takeaway: Vaping reduces but does not eliminate lung harm. It's a substantial improvement over smoking, but not risk-free. Read the full switching science analysis for success rate data.
If you're a heavy smoker with COPD or other lung conditions, consult your doctor about whether vaping or FDA-approved cessation methods (like Chantix or patches) are right for you.
The Current Vaper Worried About Health
Key takeaway: You can reduce risks by switching to simpler flavors, replacing coils regularly, and moderating consumption. Track your usage patterns to understand your actual exposure level.
If you have persistent respiratory symptoms (cough, wheezing, shortness of breath), see a doctor — don't try to self-diagnose from internet articles.
The Public Health Researcher or Policy Maker
Key takeaway: The evidence base is still immature. Strong claims about either safety or danger are premature. The most defensible policy position is harm reduction — regulated access for adult smokers combined with aggressive youth prevention.
Our breakdown of the FDA's flavored ENDS draft guidance provides additional context on the regulatory framework.
The Parent Concerned About Youth Vaping
Key takeaway: Youth vaping is a legitimate concern — not because of EVALI (which was THC carts), but because of nicotine addiction and unknown long-term effects on developing lungs and brains.
The biggest risk factor for youth vaping is peer influence and flavor appeal. For parents, open communication and factual education are more effective than scare tactics.
